AMENDED AND RESTATED ROYALTY AGREEMENTRoyalty Agreement • May 22nd, 2023 • Burzynski Research Institute Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMay 22nd, 2023 Company IndustryTHIS AMENDED AND RESTATED AGREEMENT (the "Agreement") made and entered into May 22, 2023 by and between STANISLAW R. BURZYNSKI, M.D., Ph.D. ("BURZYNSKI") with offices at 9432 Katy Freeway, Suite 200, Houston, Texas 77055 and Burzynski Research Institute, Inc. (the "Company"), a Delaware corporation with offices located at 9432 Katy Freeway, Suite 200, Houston, Texas 77055.
AMENDED AND RESTATED RESEARCH FUNDING AGREEMENTResearch Funding Agreement • May 22nd, 2023 • Burzynski Research Institute Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMay 22nd, 2023 Company IndustryTHIS AMENDED AND RESTATED AGREEMENT (the "Agreement”) effective as of May 22, 2023, by and between Stanislaw R. Burzynski, M.D. Ph.D (hereinafter "SRB") with offices at 9432 Katy Freeway, Suite 200, Houston, Texas 77055 and Burzynski Research Institute, Inc. (the "Company"), a Delaware corporation with offices located at 9432 Katy Freeway, Suite 200, Houston, Texas 77055:
LICENSE AGREEMENTLicense Agreement • May 22nd, 2023 • Burzynski Research Institute Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMay 22nd, 2023 Company IndustryLICENSE AGREEMENT dated May 22, 2023, by and between Dr. Stanislaw R. Burzynski ("Dr. Burzynski") with offices at 9432 Katy Freeway, Suite 200, Houston, Texas 77055 and Burzynski Research Institute, Inc. (the "Company"), a Delaware corporation with offices located at 9432 Katy Freeway, Suite 200, Houston, Texas 77055.